Global Drugs for Malaria Market Insights and Forecast to 2027

Global Drugs for Malaria Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Drugs for Malaria Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Malaria Sales Estimates and Forecasts 2016-2027
2.2 Global Drugs for Malaria Revenue Estimates and Forecasts 2016-2027
2.3 Global Drugs for Malaria Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Drugs for Malaria Regions by Sales
2.4.1 Global Top Drugs for Malaria Regions by Sales (2016-2021)
2.4.2 Global Top Drugs for Malaria Regions by Sales (2022-2027)
2.5 Global Top Drugs for Malaria Regions by Revenue
2.5.1 Global Top Drugs for Malaria Regions by Revenue (2016-2021)
2.5.2 Global Top Drugs for Malaria Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Malaria Sales by Manufacturers
3.1.1 Global Top Drugs for Malaria Manufacturers by Sales (2016-2021)
3.1.2 Global Top Drugs for Malaria Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Drugs for Malaria Sales in 2020
3.2 Global Drugs for Malaria Revenue by Manufacturers
3.2.1 Global Top Drugs for Malaria Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Drugs for Malaria Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2020
3.3 Global Drugs for Malaria Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Malaria Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Malaria Sales by Type
4.1.1 Global Drugs for Malaria Historical Sales by Type (2016-2021)
4.1.2 Global Drugs for Malaria Forecasted Sales by Type (2022-2027)
4.1.3 Global Drugs for Malaria Sales Market Share by Type (2016-2027)
4.2 Global Drugs for Malaria Revenue by Type
4.2.1 Global Drugs for Malaria Historical Revenue by Type (2016-2021)
4.2.2 Global Drugs for Malaria Forecasted Revenue by Type (2022-2027)
4.2.3 Global Drugs for Malaria Revenue Market Share by Type (2016-2027)
4.3 Global Drugs for Malaria Price by Type
4.3.1 Global Drugs for Malaria Price by Type (2016-2021)
4.3.2 Global Drugs for Malaria Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Drugs for Malaria Sales by Application
5.1.1 Global Drugs for Malaria Historical Sales by Application (2016-2021)
5.1.2 Global Drugs for Malaria Forecasted Sales by Application (2022-2027)
5.1.3 Global Drugs for Malaria Sales Market Share by Application (2016-2027)
5.2 Global Drugs for Malaria Revenue by Application
5.2.1 Global Drugs for Malaria Historical Revenue by Application (2016-2021)
5.2.2 Global Drugs for Malaria Forecasted Revenue by Application (2022-2027)
5.2.3 Global Drugs for Malaria Revenue Market Share by Application (2016-2027)
5.3 Global Drugs for Malaria Price by Application
5.3.1 Global Drugs for Malaria Price by Application (2016-2021)
5.3.2 Global Drugs for Malaria Price Forecast by Application (2022-2027)
6 North America
6.1 North America Drugs for Malaria Market Size by Type
6.1.1 North America Drugs for Malaria Sales by Type (2016-2027)
6.1.2 North America Drugs for Malaria Revenue by Type (2016-2027)
6.2 North America Drugs for Malaria Market Size by Application
6.2.1 North America Drugs for Malaria Sales by Application (2016-2027)
6.2.2 North America Drugs for Malaria Revenue by Application (2016-2027)
6.3 North America Drugs for Malaria Market Size by Country
6.3.1 North America Drugs for Malaria Sales by Country (2016-2027)
6.3.2 North America Drugs for Malaria Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Malaria Market Size by Type
7.1.1 Europe Drugs for Malaria Sales by Type (2017-2027)
7.1.2 Europe Drugs for Malaria Revenue by Type (2017-2027)
7.2 Europe Drugs for Malaria Market Size by Application
7.2.1 Europe Drugs for Malaria Sales by Application (2017-2027)
7.2.2 Europe Drugs for Malaria Revenue by Application (2017-2027)
7.3 Europe Drugs for Malaria Market Size by Country
7.3.1 Europe Drugs for Malaria Sales by Country (2017-2027)
7.3.2 Europe Drugs for Malaria Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria Market Size by Type
8.1.1 Asia Pacific Drugs for Malaria Sales by Type (2018-2027)
8.1.2 Asia Pacific Drugs for Malaria Revenue by Type (2018-2027)
8.2 Asia Pacific Drugs for Malaria Market Size by Application
8.2.1 Asia Pacific Drugs for Malaria Sales by Application (2018-2027)
8.2.2 Asia Pacific Drugs for Malaria Revenue by Application (2018-2027)
8.3 Asia Pacific Drugs for Malaria Market Size by Region
8.3.1 Asia Pacific Drugs for Malaria Sales by Region (2018-2027)
8.3.2 Asia Pacific Drugs for Malaria Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drugs for Malaria Market Size by Type
9.1.1 Latin America Drugs for Malaria Sales by Type (2019-2027)
9.1.2 Latin America Drugs for Malaria Revenue by Type (2019-2027)
9.2 Latin America Drugs for Malaria Market Size by Application
9.2.1 Latin America Drugs for Malaria Sales by Application (2019-2027)
9.2.2 Latin America Drugs for Malaria Revenue by Application (2019-2027)
9.3 Latin America Drugs for Malaria Market Size by Country
9.3.1 Latin America Drugs for Malaria Sales by Country (2019-2027)
9.3.2 Latin America Drugs for Malaria Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Drugs for Malaria Market Size by Type
6.1.1 Middle East and Africa Drugs for Malaria Sales by Type (2016-2027)
6.1.2 Middle East and Africa Drugs for Malaria Revenue by Type (2016-2027)
6.2 Middle East and Africa Drugs for Malaria Market Size by Application
6.2.1 Middle East and Africa Drugs for Malaria Sales by Application (2016-2027)
6.2.2 Middle East and Africa Drugs for Malaria Revenue by Application (2016-2027)
6.3 Middle East and Africa Drugs for Malaria Market Size by Country
6.3.1 Middle East and Africa Drugs for Malaria Sales by Country (2016-2027)
6.3.2 Middle East and Africa Drugs for Malaria Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Overview
11.1.3 Cipla Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Cipla Drugs for Malaria Product Description
11.1.5 Cipla Related Developments
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Overview
11.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Guilin Pharmaceutical Drugs for Malaria Product Description
11.2.5 Guilin Pharmaceutical Related Developments
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Overview
11.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 IPCA Laboratories Drugs for Malaria Product Description
11.3.5 IPCA Laboratories Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 GlaxoSmithKline Drugs for Malaria Product Description
11.4.5 GlaxoSmithKline Related Developments
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Overview
11.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mylan Labs Drugs for Malaria Product Description
11.5.5 Mylan Labs Related Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Roche Drugs for Malaria Product Description
11.6.5 Roche Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Novartis Drugs for Malaria Product Description
11.7.5 Novartis Related Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Overview
11.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sanofi Aventis Drugs for Malaria Product Description
11.8.5 Sanofi Aventis Related Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Overview
11.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Ajanta Pharma Drugs for Malaria Product Description
11.9.5 Ajanta Pharma Related Developments
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Overview
11.1.3 Cipla Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Cipla Drugs for Malaria Product Description
11.1.5 Cipla Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Drugs for Malaria Value Chain Analysis
12.2 Drugs for Malaria Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Malaria Production Mode & Process
12.4 Drugs for Malaria Sales and Marketing
12.4.1 Drugs for Malaria Sales Channels
12.4.2 Drugs for Malaria Distributors
12.5 Drugs for Malaria Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Malaria Industry Trends
13.2 Drugs for Malaria Market Drivers
13.3 Drugs for Malaria Market Challenges
13.4 Drugs for Malaria Market Restraints
14 Key Findings in The Global Drugs for Malaria Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Aryl Aminoalcohol Compounds
Table 3. Major Manufacturers of Antifolate Compounds
Table 4. Major Manufacturers of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Drugs for Malaria Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 8. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 9. Global Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 10. Global Drugs for Malaria Sales Market Share by Region (2022-2027)
Table 11. Global Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 13. Global Drugs for Malaria Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Drugs for Malaria Revenue Market Share by Region (2022-2027)
Table 15. Global Drugs for Malaria Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Drugs for Malaria Sales Share by Manufacturers (2016-2021)
Table 17. Global Drugs for Malaria Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Drugs for Malaria Revenue Share by Manufacturers (2016-2021)
Table 19. Drugs for Malaria Price by Manufacturers 2016-2021 (USD/Unit)
Table 20. Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2020)
Table 22. Drugs for Malaria Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drugs for Malaria Product Offered
Table 24. Date of Manufacturers Enter into Drugs for Malaria Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 27. Global Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 28. Global Drugs for Malaria Sales Share by Type (2016-2021)
Table 29. Global Drugs for Malaria Sales Share by Type (2022-2027)
Table 30. Global Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Drugs for Malaria Revenue Share by Type (2016-2021)
Table 33. Global Drugs for Malaria Revenue Share by Type (2022-2027)
Table 34. Drugs for Malaria Price by Type (2016-2021) & (USD/Unit)
Table 35. Global Drugs for Malaria Price Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 37. Global Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 38. Global Drugs for Malaria Sales Share by Application (2016-2021)
Table 39. Global Drugs for Malaria Sales Share by Application (2022-2027)
Table 40. Global Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Drugs for Malaria Revenue Share by Application (2016-2021)
Table 43. Global Drugs for Malaria Revenue Share by Application (2022-2027)
Table 44. Drugs for Malaria Price by Application (2016-2021) & (USD/Unit)
Table 45. Global Drugs for Malaria Price Forecast by Application (2022-2027) & (USD/Unit)
Table 46. North America Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 47. North America Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 48. North America Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 51. North America Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 52. North America Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 55. North America Drugs for Malaria Sales by Country (2022-2027) & (K Units)
Table 56. North America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 59. Europe Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 60. Europe Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 63. Europe Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 64. Europe Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 67. Europe Drugs for Malaria Sales by Country (2022-2027) & (K Units)
Table 68. Europe Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Drugs for Malaria Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Drugs for Malaria Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Drugs for Malaria Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Drugs for Malaria Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Drugs for Malaria Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Drugs for Malaria Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
Table 106. Cipla Corporation Information
Table 107. Cipla Description and Major Businesses
Table 108. Cipla Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. Cipla Drugs for Malaria Product
Table 110. Cipla Recent Developments
Table 111. Guilin Pharmaceutical Corporation Information
Table 112. Guilin Pharmaceutical Description and Major Businesses
Table 113. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Guilin Pharmaceutical Drugs for Malaria Product
Table 115. Guilin Pharmaceutical Recent Developments
Table 116. IPCA Laboratories Corporation Information
Table 117. IPCA Laboratories Description and Major Businesses
Table 118. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. IPCA Laboratories Drugs for Malaria Product
Table 120. IPCA Laboratories Recent Developments
Table 121. GlaxoSmithKline Corporation Information
Table 122. GlaxoSmithKline Description and Major Businesses
Table 123. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. GlaxoSmithKline Drugs for Malaria Product
Table 125. GlaxoSmithKline Recent Developments
Table 126. Mylan Labs Corporation Information
Table 127. Mylan Labs Description and Major Businesses
Table 128. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Mylan Labs Drugs for Malaria Product
Table 130. Mylan Labs Recent Developments
Table 131. Roche Corporation Information
Table 132. Roche Description and Major Businesses
Table 133. Roche Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Roche Drugs for Malaria Product
Table 135. Roche Recent Developments
Table 136. Novartis Corporation Information
Table 137. Novartis Description and Major Businesses
Table 138. Novartis Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Novartis Drugs for Malaria Product
Table 140. Novartis Recent Developments
Table 141. Sanofi Aventis Corporation Information
Table 142. Sanofi Aventis Description and Major Businesses
Table 143. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. Sanofi Aventis Drugs for Malaria Product
Table 145. Sanofi Aventis Recent Developments
Table 146. Ajanta Pharma Corporation Information
Table 147. Ajanta Pharma Description and Major Businesses
Table 148. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. Ajanta Pharma Drugs for Malaria Product
Table 150. Ajanta Pharma Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Drugs for Malaria Distributors List
Table 154. Drugs for Malaria Customers List
Table 155. Drugs for Malaria Market Trends
Table 156. Drugs for Malaria Market Drivers
Table 157. Drugs for Malaria Market Challenges
Table 158. Drugs for Malaria Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Share by Type in 2020 & 2027
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Drugs for Malaria Sales Market Share by Application in 2020 & 2027
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Others
Figure 10. Drugs for Malaria Report Years Considered
Figure 11. Global Drugs for Malaria Sales 2016-2027 (K Units)
Figure 12. Global Drugs for Malaria Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drugs for Malaria Revenue 2016-2027 (US$ Million)
Figure 14. Global Drugs for Malaria Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Figure 16. Global Drugs for Malaria Sales Market Share by Region (2022-2027)
Figure 17. North America Drugs for Malaria Sales YoY (2016-2027) & (K Units)
Figure 18. North America Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Drugs for Malaria Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Drugs for Malaria Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Drugs for Malaria Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Drugs for Malaria Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Drugs for Malaria Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Drugs for Malaria Revenue in 2020
Figure 29. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 31. Global Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 32. Global Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 33. Global Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 34. North America Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 35. North America Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 36. North America Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 37. North America Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 38. North America Drugs for Malaria Sales Share by Country (2016-2027)
Figure 39. North America Drugs for Malaria Revenue Share by Country (2016-2027)
Figure 40. U.S. Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 43. Europe Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 44. Europe Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 45. Europe Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 46. Europe Drugs for Malaria Sales Share by Country (2016-2027)
Figure 47. Europe Drugs for Malaria Revenue Share by Country (2016-2027)
Figure 48. Germany Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 49. France Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Drugs for Malaria Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Drugs for Malaria Revenue Share by Region (2016-2027)
Figure 59. China Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 62. India Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 70. Latin America Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 72. Latin America Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Drugs for Malaria Sales Share by Country (2016-2027)
Figure 74. Latin America Drugs for Malaria Revenue Share by Country (2016-2027)
Figure 75. Mexico Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Drugs for Malaria Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Drugs for Malaria Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Drugs for Malaria Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Drugs for Malaria Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Drugs for Malaria Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Drugs for Malaria Revenue Share by Country (2016-2027)
Figure 84. Turkey Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Drugs for Malaria Revenue (2016-2027) & (US$ Million)
Figure 87. Drugs for Malaria Value Chain
Figure 88. Drugs for Malaria Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs